Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth)

Navigation and Search

News Archive



Team assessing if dual-antibody injection prevents COVID-19 illness

A woman receives a vaccine in her arm. (Photo by: Getty Images)

September 24, 2020

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.




Preparing for asthma attacks during a pandemic

Pushan Jani, MD, says every year toward the end of September and into October, he sees a significant uptick in asthma-related hospitalizations as various pollens such as ragweed and mold hit the air. (Photo by: Getty Images)

September 23, 2020

Cooler weather, pumpkins, and falling leaves – all things that kick off the most wonderful time of year, the holiday season. But for asthma sufferers, this could mean trouble because experts see an increase in asthma attacks toward the end of September.


UTHealth joins NIH trial to test antibodies and other experimental outpatient treatments for mild COVID-19 pneumonia

The first treatment being tested is LY-CoV555, an investigational monoclonal (laboratory-manufactured) antibody developed from the blood sample of a recovered COVID-19 patient. (Photo by: Getty Images)

September 15, 2020

A study on the effectiveness of multiple treatments, including laboratory-made antibodies, at preventing mild COVID-19 from advancing to severe illness in the outpatient setting is underway by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.




Oderich joins UTHealth as Chief of Vascular and Endovascular Surgery

Gustavo Oderich, MD, FACS, has been named chief of the vascular surgery division with the Department of Cardiothoracic and Vascular Surgery at UTHealth. (Photo by: Dwight Andrews, UTHealth)

September 11, 2020

Gustavo Oderich, MD, FACS, a noted leader in the field of vascular and endovascular surgery, has been named chief of the vascular surgery division with the Department of Cardiothoracic and Vascular Surgery at The University of Texas Health Science Center at Houston (UTHealth).  He will serve as professor of vascular and endovascular surgery at McGovern Medical School at UTHealth and director of the Advanced Endovascular Aortic Program.



Page 1 of 58


Search UTHealth News

Use the form below to perform a new search.